Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.
Gene replacement therapy for the neurological deficits caused by lysosomal storage disorders, such as in Niemann-Pick disease type A, will require widespread expression of efficacious levels of acid sphingomyelinase (ASM) in the infant human brain. At present there is no treatment available for this devastating pediatric condition. This is partly because of inherent constraints associated with the efficient delivery of therapeutic agents into the CNS of higher order models. In this study we used an adeno-associated virus type 2 (AAV2) vector encoding human acid sphingomyelinase tagged with a viral hemagglutinin epitope (AAV2-hASM-HA) to transduce highly interconnected CNS regions such as the brainstem and thalamus. On the basis of our data showing global cortical expression of a secreted reporter after thalamic delivery in nonhuman primates (NHPs), we set out to investigate whether such widespread expression could be enhanced after brainstem infusion. To maximize delivery of the therapeutic transgene throughout the CNS, we combined a single brainstem infusion with bilateral thalamic infusions in naive NHPs. We found that enzymatic augmentation in brainstem, thalamic, cortical, as well subcortical areas provided convincing evidence that much of the large NHP brain can be transduced with as few as three injection sites.
Salegio
E Aguilar
EA
Department of Neurosurgery, University of California San Francisco, 94103, USA.
Kells
A P
AP
Richardson
R M
RM
Hadaczek
P
P
Forsayeth
J
J
Bringas
J
J
Sardi
S P
SP
Passini
M A
MA
Shihabuddin
L S
LS
Cheng
S H
SH
Fiandaca
M S
MS
Bankiewicz
K S
KS
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D000229:Dependovirus / Q000235:genetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D007430:Intraoperative Care; D016464:Lysosomal Storage Diseases / Q000235:genetics* / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D009474:Neurons / Q000378:metabolism; D011323:Primates; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics / Q000627:therapeutic use; D014161:Transduction, Genetic; D019076:Transgenes / Q000235:genetics
D013108:Sphingomyelin Phosphodiesterase
Curr Opin Drug Discov Devel. 2003 Mar;6(2):174-8
12669452
Neurotherapeutics. 2008 Jan;5(1):123-7
18164491
Hum Gene Ther. 2000 May 20;11(8):1139-50
10834616
Exp Neurol. 2008 Apr;210(2):638-44
18295759
Brain Res Brain Res Protoc. 2005 Dec;16(1-3):20-6
16181805
J Neurooncol. 2002 Jul;58(3):187-92
12187954
Gene Ther. 1998 Oct;5(10):1314-21
9930336
Hum Gene Ther. 2004 Nov;15(11):1131-54
15610613
Prog Brain Res. 2009;175:163-72
19660655
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9505-10
17517638
Mol Ther. 2006 Jul;14(1):69-78
16650807
Hum Gene Ther. 1999 Jul 1;10(10):1667-82
10428212
Hum Gene Ther. 1998 May 20;9(8):1181-6
9625257
J Neurochem. 1994 Sep;63(3):1060-8
8051547
J Neurosci. 2007 Sep 12;27(37):9928-40
17855607
Gene Ther. 1998 Jul;5(7):938-45
9813665
Lancet. 2007 Jun 23;369(9579):2097-105
17586305
Exp Neurol. 2008 Jan;209(1):51-7
17920059
J Neurosurg. 2007 Sep;107(3):560-7
17886556
Neurology. 2009 Nov 17;73(20):1662-9
19828868
Neuroimage. 2009 Aug;47 Suppl 2:T27-35
19095069
Cell. 1995 Jun 30;81(7):1053-61
7600574
Hum Gene Ther. 2002 Jul 20;13(11):1391-412
12162821
Lancet Neurol. 2008 May;7(5):400-8
18387850
J Neurosurg. 2008 Nov;109(5):874-80
18976077
J Neurosurg. 2007 Jul;107(1):190-7
17639894
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2407-11
19193857
Neurology. 2008 May 20;70(21):1980-3
18401019
Hum Gene Ther. 2002 Mar 20;13(5):579-604
11916483
Hum Mol Genet. 2000 Aug 12;9(13):1967-76
10942425
Mol Ther. 2006 Oct;14(4):564-70
16829205
N Engl J Med. 1991 May 23;324(21):1464-70
2023606
Mol Ther. 2005 May;11(5):754-62
15851014
J Neurosurg. 1999 Feb;90(2):315-20
9950503
Hum Gene Ther. 2009 Mar;20(3):225-37
19292604
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17822-7
16301517
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5885-9
7597047
Neuroreport. 2006 Feb 6;17(2):201-4
16407771
Expert Opin Biol Ther. 2001 Sep;1(5):857-67
11728220
Mol Ther. 2005 Sep;12(3):431-40
16099409
Methods Mol Med. 2003;76:383-403
12526176
J Neurosurg. 2010 Aug;113(2):240-8
20367078
Mol Ther. 2008 Jul;16(7):1267-75
18523450
Neuroimage. 2011 Jan;54 Suppl 1:S196-203
19761848
Biochem Biophys Res Commun. 2004 May 28;318(2):381-90
15120612